Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Rank in Stocks #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Share Price
$0.2219522
Last synced: 2025-09-11
Market Cap
$1.10B
Change (1 day)
0.04%
Change (1 year)
0.17%
Country
CN
Trade Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Earnings for Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Earnings in Sep 2024 TTM: $-246.31M
According to Hubei Biocause Pharmaceutical Co., Ltd. latest financial reports the company's current earnings are $-246.31M. In 2022 the company made an earning of $32.59M, a decrease compared to its 2021 earnings that were of $53.98M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Hubei Biocause Pharmaceutical Co., Ltd. from 2000 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-246.31M -6.66%
2023 $-263.90M -909.84%
2022 $32.59M -39.64%
2021 $53.98M -75.67%
2020 $221.88M -57.48%
2019 $521.80M 36.14%
2018 $383.27M -8.47%
2017 $418.73M -15.31%
2016 $494.40M 859.98%
2015 $51.50M 192.79%
2014 $17.59M -182.99%
2013 $-21.20M -981.31%
2012 $2.40M -112.99%
2011 $-18.51M -493.30%
2010 $4.71M -45.74%
2009 $8.67M 709.23%
2008 $1.07M -93.04%
2007 $15.40M 107.42%
2006 $7.42M 610.69%
2005 $1.04M 72.62%
2004 $605.05K -110.58%
2003 $-5.72M -392.76%
2002 $1.95M -72.00%
2001 $6.97M 18.03%
2000 $5.91M 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$43.81B -17,885.82%
CN
$9.54B -3,973.90%
HK
- -
CA
- -
TW
- -
US